Li, Li
Conradson, Devon M.
Bharat, Vinita
Kim, Min Joo
Hsieh, Chung-Han http://orcid.org/0000-0002-2181-9336
Minhas, Paras S.
Papakyrikos, Amanda M.
Durairaj, Aarooran Sivakumaran
Ludlam, Anthony
Andreasson, Katrin I.
Partridge, Linda http://orcid.org/0000-0001-9615-0094
Cianfrocco, Michael A.
Wang, Xinnan http://orcid.org/0000-0002-2640-7082
Funding for this research was provided by:
Glenn Family Foundation
Parkinson’s UK
U.S. Department of Defense
Article History
Received: 11 December 2020
Accepted: 27 July 2021
First Online: 9 September 2021
Competing interests
: X.W. is a co-founder, adviser and shareholder of AcureX Therapeutics Inc., and a shareholder of Mitokinin Inc. L.L. and C.-H.H. are shareholders of AcureX Therapeutics Inc. A patent on Miro1 Reducers was filed by Stanford University with X.W., C.-H.H. and L.L. as inventors. The remaining authors declare no competing interests.